Study reveals how cancer drug helps to restore immune system's ability to fight tumours

A group led by scientists at The University of Texas at Austin has discovered a brandnew bioinspired medication that restores the capability of immune cells to combat cancer The medication increases the effectiveness of immunotherapy and inhibits tumour growth in mice models of melanoma bladder cancer leukemia and colon cancerThe findings of the research published in the journal Cancer Cell and could be a game changer for many cancer patientsA DNA segment known as 9p21 which is frequently deleted in tumours and occurs in 25 per cent 50 per cent of various cancers such melanoma bladder cancer mesothelioma and several brain cancers is frequently deleted Longstanding research has shown that malignancies with the 9p21 deletion have worse prognoses for patients and are more resistant to immunotherapies which are cancer treatments that boost a patients innate immune systemThe deletion helps cancer cells avoid getting detected and wiped out by the immune system in part by prompting the cancer to pump out a toxic compound called MTA that impairs normal functioning of immune cells and also blocks the effectiveness of immunotherapiesIn animal models our drug lowers MTA back down to normal and the immune system comes back on said Everett Stone a research associate professor in the Department of Molecular Biosciences and associate professor of oncology at Dell Medical School who led the work We see a lot more T cells around the tumor and theyre in attack mode T cells are an important immune cell type like a SWAT team that can recognize tumor cells and pump them full of enzymes that chew up the tumor from the inside outStone envisions the drug being used in combination with immunotherapies to boost their effectivenessThe studys cofirst authors are Donjeta Gjuka a former UT postdoctoral researcher and currently a scientist at Takeda Oncology and Elio Adib formerly a postdoctoral researcher at Brigham and Womens Hospital and the DanaFarber Cancer Institute and currently a resident physician at Mass General BrighamThe 9p21 deletion leads to the loss of some key genes in cancer cells Gone are a pair of genes that produce cell cycle regulators proteins that keep healthy cells growing and dividing at a slow steady rate When those genes are lost cells can grow unchecked Thats what makes them cancerous Also deleted is a housekeeping gene that produces an enzyme that breaks down the toxin MTA Its this loss according to Stone that lets cancer cells acquire a new superpower the ability to deactivate the immune systemCancer gets a twoforone when it loses both of these genes Stone said It loses the brakes that normally keep it from growing in an uncontrolled manner And then at the same time it disarms the bodys police force So it becomes a much more aggressive and malignant kind of cancerTo create their drug candidate Stone and his colleagues started with the helpful enzyme thats naturally produced by the body to break down MTA and then added flexible polymersIts already a really good enzyme but we needed to optimize it to last longer in the body Stone said If we injected just the natural enzyme it would be eliminated within a few hours In mice our modified version stays in circulation for days in humans it will last even longerThis story has been sourced from a third party syndicated feed agencies Midday accepts no responsibility or liability for its dependability trustworthiness reliability and data of the text Midday managementmiddaycom reserves the sole right to alter delete or remove without notice the content in its absolute discretion for any reason whatsoever